The publication detail shows the title, authors (with indicators showing other profiled authors), information on the publishing organization, abstract and a link to the article in PubMed. This abstract is what is used to create the fingerprint of the publication. If any grants are referenced by the publication, they will be listed here as well.
Electronic health record-based monitoring of primary care patients at risk of medication-related toxicity.
David G Bundy; Jill A Marsteller; Albert W Wu; Lilly D Engineer; Sean M Berenholtz; A Harrison Caughey; David Silver; Jing Tian; Richard E Thompson; Marlene R Miller; et al. (Profiled Authors: Albert Wu; Jing Tian; Christoph Lehmann; Jill Marsteller; David Gordon Bundy; Lilly Engineer; Richard Thompson; Sean Berenholtz; Marlene Miller)
Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, USA. firstname.lastname@example.org
Joint Commission journal on quality and patient safety / Joint Commission Resources 2012;38(5):216-23.
BACKGROUND: Timely laboratory monitoring may reduce the potential harm associated with chronic medication use. A study was conducted to determine the proportion of patients receiving National Committee for Quality Assurance (NCQA)-recommended laboratory medication monitoring in a primary care setting and to assess the effect of electronic health record (EHR)-derived, paper-based, provider-specific feedback bulletins on subsequent patient receipt of medication monitoring. METHODS: In a single-arm, pre-post intervention in two federally qualified community health centers in Baltimore, patients targeted were adults prescribed at least 6 months (in the preceding year) for at least one index medication (digoxin, statins, diuretics, angiotensin-converting enzyme inhibitors/ angiotensin II-receptor blockers) in a 12-month period (August 2008-July 2009). RESULTS: Among the 2,013 patients for whom medication monitoring was recommended, 42% were overdue for monitoring at some point during the study. As the number of index medications the patient was prescribed increased, the likelihood of ever being overdue for monitoring decreased. Being listed on the provider-specific monitoring bulletin doubled the odds of a patient receiving recommended laboratory monitoring before the next measurement period (1-2 months). Limiting the intervention to the most overdue patients, however, mitigated its overall impact. CONCLUSIONS: Recommended laboratory monitoring of chronic medications appears to be inconsistent in primary care, resulting in potential harm for individuals at risk for medication-related toxicity. EHRs may be an important component of systems designed to improve medication monitoring, but multimodal interventions will likely be needed to achieve high reliability.
This section shows information related to the publication - computed using the fingerprint of the publication - including related publications, related experts and related grants with fingerprints representing significant amounts of overlap between their fingerprint and this publication. The red dots indicate whether those experts or terms appear within the publication, thereby showing potential and actual connections.
Jerilyn K Allen; Cheryl R Dennison Himmelfarb; Sarah L Szanton; Lee Bone; Martha N Hill; David M LevineContemporary clinical trials 2011;32(3):403-11.
Janice V Bowie; Anita M Wells; Hee-Soon Juon; Kim D Sydnor; Elisa M RodriguezJournal of community health 2008;33(4):183-91.
Jeanne C Keruly; Richard Conviser; Richard D MooreAmerican journal of public health 2002;92(5):852-7.
Appears in this Publication
Author of this Publication